Splenic marginal zone lymphoma: A US population-based survival analysis (1999-2016).
Jorge A FlorindezJuan Pablo AlderuccioIsildinha M ReisIzidore S LossosPublished in: Cancer (2020)
There were no significant differences in overall or SMZL-specific survival by treatment strategy. Older age, Hispanic ethnicity, DLBCL transformation, and B-symptoms were associated with a worse prognosis.